DSP-1181
On 30th January 2020 Exscientia announced the first molecule designed by Artificial Intelligence (AI) to enter a Phase 1 Clinical trial.

On 30th January 2020 Exscientia announced the first molecule designed by Artificial Intelligence (AI) to enter a Phase 1 Clinical trial.